BioSpace News Archive

CONCIERGE KEY Health™ (CKH) — appoints Jennifer Anderson as CEO of its growing health and wellness membership brand. With more than 15 years in the consumer and health technology industry, Anderson brings vast knowledge and expertise, aiming to scale the business to higher levels and fully commercialize the AccessElite product portfolio.

At the 67th American Society for Mass Spectrometry Conference (ASMS) being held June 2-6 in Atlanta, Bruker is announcing highly innovative new mass spectrometry products and workflows:

ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that it has amended its license agreement with CSL Limited (CSL) so that ASLAN has full global rights to develop, manufacture and commercialise ASLAN004 in all indications

Three of the board members of Nordic Nanovector ASA, Gisela Schwab, Joanna Horobin and Jean-Pierre Bizzari, have resolved to settle a total number of 11,840 RSUs that were issued to them in June 2018 after they had elected to receive all or part of their remuneration for the period from the annual general meeting in 2018 to the annual general meeting in 2019 in RSUs.

As we recognize World No Tobacco Day, we must acknowledge the concerning increase in vaping and e-cigarette use among younger Canadians.

Centene to Preview Additional Details of Organizational Structure for Combined Company at Investor Day Scheduled for June 14, 2019

Also Presenting Preclinical Data on Two Additional Pipeline Products

A new proprietary extract called Diosterol™ from Dioscorea Nipponica Makino has been released in the United States.

EIP Pharma, Inc. announced that company management will present at two investor conferences in June.

ReNeuron Group plc announced that ReNeuron’s management team will participate in 1-on-1 meetings at the Jefferies 2019 Global Healthcare Conference on Tuesday, June 4, 2019 in New York City.